- NexImmune Announces Closing of $3.67 Million Registered Direct Offering Priced At-the-Market Under Nasdaq Rules
- NexImmune Announces $3.67 Million Registered Direct Offering Priced At-the-Market Under Nasdaq Rules
- NexImmune, Yale, and JDRF Extend Research Partnership for Type 1 Diabetes
- NexImmune Announces Presentations at The Society for Immunotherapy of Cancer’s 38th Annual Meeting
- NexImmune Announces 1-for-25 Reverse Stock Split
- NexImmune Announces Workforce Reduction to Enable Continued AIMTM Nanoparticle Platform Development Strategy
- NexImmune Reports Second Quarter 2023 Financial Results and Provides Business Updates
More ▼
Key statistics
On Thursday, Neximmune Inc (NEXI:PKC) closed at 1.38, 10.39% above the 52 week low of 1.25 set on Nov 24, 2023.
52-week range
Short selling activityProvided by S&P Global Market Intelligence
Open | 1.58 |
---|---|
High | 1.58 |
Low | 1.36 |
Bid | -- |
Offer | -- |
Previous close | 1.63 |
Average volume | 127.75k |
---|---|
Shares outstanding | 1.37m |
Free float | 1.14m |
P/E (TTM) | -- |
Market cap | 2.23m USD |
EPS (TTM) | -24.16 USD |
Data delayed at least 15 minutes, as of Jul 25 2024 20:59 BST.
More ▼